This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Institute of Life Sciences. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Inventor Profile: Fahima Dilnawaz
Introduction
Fahima Dilnawaz is a distinguished inventor based in Orissa, India. She has made significant contributions to the field of biomedical innovation, particularly in drug delivery systems. Her pioneering work encapsulates a new approach in utilizing magnetic nanoparticles for enhanced medical applications.
Latest Patents
Fahima holds one patent for her innovative invention titled "Water dispersible glyceryl monooleate magnetic nanoparticle formulation." This invention revolves around an aqueous dispersible magnetic nanoparticle formulation that exhibits a high drug loading capacity, used for sustained drug delivery. The formulated magnetic nanoparticles feature an iron oxide core coated with a long-chain polymer, ensuring aqueous dispersibility without the need for surfactants. She has also devised a method for the functionalization of these magnetic nanoparticles specifically for applications in the biomedical field.
Career Highlights
Fahima is currently affiliated with the Institute of Life Sciences, where she continues to explore and develop cutting-edge technologies in her area of expertise. Her dedication to research and innovation has positioned her as a valuable asset in the scientific community.
Collaborations
Throughout her career, Fahima has collaborated with notable colleagues, including Sanjeeb Kumar Sahoo and Abhalami Singh Singh. These partnerships have facilitated the exchange of ideas and knowledge, further enhancing the caliber of her research and innovations.
Conclusion
Fahima Dilnawaz stands out as a prominent inventor whose work in magnetic nanoparticle formulation significantly impacts the biomedical field. Her contributions not only advance scientific understanding but also pave the way for improved drug delivery methods. As her career unfolds, the innovation community eagerly anticipates her future endeavors and breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile